Patterns of Cardiopulmonary health across the life course
整个生命过程中心肺健康的模式
基本信息
- 批准号:10634635
- 负责人:
- 金额:$ 67.79万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-09-01 至 2026-05-31
- 项目状态:未结题
- 来源:
- 关键词:AdultAffectAgeAge of OnsetAir PollutionAncillary StudyBiological AssayBiological MarkersBiological ProcessBlack raceCardiacCardiac healthCardiopulmonaryCardiovascular systemCause of DeathChronic lung diseaseClinicalCoronary Artery Risk Development in Young Adults StudyDataDetectionDiseaseEFRACEchocardiographyElderlyEpidemiologyEventEvolutionFour-dimensionalFunctional disorderGoalsHealthHealth TransitionHeartHeart DiseasesHeart failureImageImpairmentIndividualInflammationInflammatoryInterventionJointsLeftLeft ventricular structureLifeLife Cycle StagesLinkLungLung diseasesMagnetic Resonance ImagingMeasuresMechanicsMediatingMediatorMorbidity - disease rateMultimodal ImagingNational Heart, Lung, and Blood InstituteOutcome StudyParticipantPathway interactionsPatternPhenotypePredispositionPreventionPrevention strategyProteomicsPublic HealthPulmonary EmphysemaPulmonary Heart DiseasePulmonary HypertensionRaceResearchRespiratory Tract InfectionsRiskRisk FactorsRisk MarkerScanningSex DifferencesSpirometryStrategic visionStructureSymptomsSystems BiologyTestingTimeTobaccoTobacco useUnited StatesVentricularVentricular End-Diastolic VolumesViral Respiratory Tract InfectionWorkX-Ray Computed Tomographyadvanced diseaseblood-based biomarkercardiac magnetic resonance imagingclinically relevantcomorbiditycritical perioddesigndisorder preventionhealth care service utilizationhemodynamicsimaging studylung healthlung injurymiddle agemortalitymultidisciplinarynovelphenotypic datapulmonary functionresiliencerisk sharingscreeningtheoriestobacco exposureyoung adult
项目摘要
ABSTRACT
Chronic lung disease and heart failure (HF) are highly prevalent, commonly co-occur, and are associated with
significant morbidity and mortality. Work from our group and others has demonstrated an independent
relationship between chronic lung disease and incident HF that may be driven in part by inflammation. We have
also documented that even in the absence of symptomatic lung disease, impaired lung function defined by
spirometry is associated with adverse cardiac remodeling on echocardiography and incident HF events. While
symptomatic lung disease and HF often occur in the elderly, many younger adults have relatively asymptomatic
impairment in lung health and cardiac structure and function. These subclinical cardiopulmonary abnormalities
develop during the key modifiable period from young adulthood to midlife. However, data are sparse on the
timing and associated mechanisms of the transition from health to disease spanning young adulthood to midlife,
and related race-sex differences. Without identifying these unique patterns of change, it will not be possible to
screen for subclinical changes and employ prevention strategies prior to irreversible damage in the lung and
heart. This requires upstream identification at the earliest detectable change. While spirometry is the gold
standard for lung disease detection, it is a relatively crude and insensitive measure of impaired lung health. In
contrast, lung injury (quantified using a novel local histogram analysis developed and validated by our group)
from computed tomography (CT) scans is a more sensitive and earlier indicator of impaired lung health (e.g. due
to tobacco, air pollution, and respiratory viral infection). Therefore, we now propose to take advantage of the
Coronary Artery Risk Development in Young Adults (CARDIA) study’s unique platform to study the temporal
relationship of and mechanisms underlying the transition from lung and heart health to disease. To-date, our
group has investigated the predictors and consequences of impaired lung health and HF, separately, in CARDIA.
In this project, we will build upon our prior work by analyzing CT scans to determine the concurrent evolution of
lung injury and adverse cardiac remodeling and identify mechanisms by assaying a multitude of blood-based
biomarkers (using a multiplexed array) and performing 4-dimensional flow cardiovascular magnetic resonance
imaging (cMRI). We will test the hypothesis that detailed imaging and blood-based markers can inform clinically
relevant endotypes reflecting dynamic changes in lung injury and adverse cardiac remodeling during a key
vulnerable period of life through the following specific aims: (1) Determine the longitudinal association between
lung injury and left ventricular end-diastolic volume (LVEDV); (2) Determine the risk of subclinical and clinical HF
among joint lung injury and LVEDV trajectory groups; and (3) Determine the hemodynamic mediators of the
association between lung injury and adverse cardiac remodeling. This study will investigate factors associated
with transitions from cardiopulmonary health to disease and associated mechanisms, and in doing so, will identify
screening strategies and contribute novel pathways for targeted disease interception of lung and heart disease.
抽象的
慢性肺部疾病和心力衰竭(HF)高度普遍,通常是同时发生的,并且与
显着的发病率和死亡率。我们小组和其他人的工作表现出了独立
慢性肺疾病与事件HF之间的关系可能部分由炎症驱动。我们有
还记录到,即使没有症状性肺病,肺功能受损
肺活量测定法与超声心动图和事件HF事件的不良心脏重塑有关。尽管
有症状的肺部病和HF通常发生在老年人中,许多年轻人患有相对无症状的年轻人
肺部健康和心脏结构和功能的损害。这些亚临床心肺异常
从成年到中年的关键可修改时期发展。但是,数据在
从健康到中年的疾病过渡到疾病的时间和相关机制,
和相关的种族性差异。如果不确定这些独特的变化模式,就不可能
在肺部发生不可逆损害之前,筛选亚临床变化和员工预防策略
心。这需要最早可检测到的上游标识。而肺活量测定法是黄金
肺部疾病检测的标准是对肺部健康受损的相对粗略和不敏感的测量。
对比,肺损伤(使用我们小组开发和验证的新型局部直方图分析进行了量子)
来自计算机断层扫描(CT)扫描是一个更敏感的肺部健康状况不佳的指标(例如
烟草,空气污染和呼吸道病毒感染)。因此,我们现在建议利用
年轻人的冠状动脉风险发展(Cardia)研究的独特平台研究临时性
从肺和心脏健康转变为疾病的过渡的关系和机制的关系。迄今为止,我们的
集团在Cardia中分别研究了肺部健康和HF受损的预测因素和后果。
在这个项目中,我们将通过分析CT扫描来确定同时发展的基础
肺损伤和不良心脏重塑,并通过分析多种血液来识别机制
生物标志物(使用多重阵列)并执行4维流量心血管磁共振
成像(CMRI)。我们将测试以下假设,即详细的成像和基于血液的标记可以在临床上告知
相关的内型反映了肺部肺损伤和不良心脏重塑的动态变化
通过以下特定目的通过以下特定目标:(1)确定纵向关联
肺部损伤和左心室末端 - 舒张体积(LVEDV); (2)确定亚临床和临床HF的风险
在关节肺损伤和LVEDV轨迹组中; (3)确定的血流动力学介质
肺损伤和不良心脏重塑之间的关联。这项研究将研究相关的因素
通过从心肺健康到疾病和相关机制的过渡,这样做会确定
筛查策略,并为肺部疾病和心脏病的靶向疾病拦截贡献新的途径。
项目成果
期刊论文数量(14)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
The 2017 American College of Cardiology/American Heart Association Hypertension Guideline and Blood Pressure in Older Adults.
2017 年美国心脏病学会/美国心脏协会高血压指南和老年人血压。
- DOI:10.1016/j.amepre.2023.04.011
- 发表时间:2023
- 期刊:
- 影响因子:5.5
- 作者:Wang,MichaelC;Petito,LuciaC;Pool,LindsayR;Foti,Kathryn;Juraschek,StephenP;McEvoy,JohnW;Nambi,Vijay;Carnethon,MercedesR;Michos,ErinD;Khan,SadiyaS
- 通讯作者:Khan,SadiyaS
Moving the Paradigm Forward for Prediction and Risk-Based Primary Prevention of Heart Failure in Special Populations.
推动特殊人群心力衰竭预测和基于风险的一级预防的范例。
- DOI:10.1007/s11883-022-01009-7
- 发表时间:2022
- 期刊:
- 影响因子:5.8
- 作者:Everitt,IanK;Trinh,KatherineV;Underberg,DanielL;Beach,Lauren;Khan,SadiyaS
- 通讯作者:Khan,SadiyaS
Cardiovascular Health in the Postpartum Period.
产后的心血管健康。
- DOI:10.1001/jama.2023.19192
- 发表时间:2023
- 期刊:
- 影响因子:0
- 作者:Khan,SadiyaS;Grobman,WilliamA;Cameron,NatalieA
- 通讯作者:Cameron,NatalieA
Social and Psychosocial Determinants of Racial and Ethnic Differences in Cardiovascular Health in the United States Population.
美国人口心血管健康种族和民族差异的社会和心理社会决定因素。
- DOI:10.1161/circulationaha.122.061991
- 发表时间:2023
- 期刊:
- 影响因子:37.8
- 作者:Shah,NilayS;Huang,Xiaoning;Petito,LuciaC;Bancks,MichaelP;Ning,Hongyan;Cameron,NatalieA;Kershaw,KiarriN;Kandula,NamrathaR;Carnethon,MercedesR;Lloyd-Jones,DonaldM;Khan,SadiyaS
- 通讯作者:Khan,SadiyaS
Leveraging the Metabolome: Translating Social Risk Into Biological Pathways.
- DOI:10.1161/circresaha.122.321700
- 发表时间:2022-09-16
- 期刊:
- 影响因子:20.1
- 作者:Mehta, Rupal;Khan, Sadiya S.
- 通讯作者:Khan, Sadiya S.
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Sadiya Sana Khan其他文献
DEVELOPMENT AND VALIDATION OF LONG-TERM RISK MODELS FOR PREDICTION OF ATHEROSCLEROTIC CARDIOVASCULAR DISEASE (ASCVD): THE CARDIOVASCULAR LIFETIME RISK POOLING PROJECT (LRPP)
- DOI:
10.1016/s0735-1097(24)03662-3 - 发表时间:
2024-04-02 - 期刊:
- 影响因子:
- 作者:
James W. Guo;Hongyan Ning;Sadiya Sana Khan;John Wilkins;Donald M. Lloyd-Jones - 通讯作者:
Donald M. Lloyd-Jones
ASSOCIATION BETWEEN CHANGES IN AGE DISTRIBUTION OF BIRTHING INDIVIDUALS AND ADVERSE PREGNANCY OUTCOMES IN THE UNITED STATES, 2011-2019
- DOI:
10.1016/s0735-1097(23)02299-4 - 发表时间:
2023-03-07 - 期刊:
- 影响因子:
- 作者:
Zachary Hughes;Lydia Hughes;Lucia Petito;william grobman;Sadiya Sana Khan - 通讯作者:
Sadiya Sana Khan
DIABETES RISK IN ADULTS WITH NORMAL WEIGHT IN THE UNITED STATES, 2013-2020
- DOI:
10.1016/s0735-1097(23)02316-1 - 发表时间:
2023-03-07 - 期刊:
- 影响因子:
- 作者:
Rahul Aggarwal;Sadiya Sana Khan;Nicholas Chiu;Muthiah Vaduganathan;Deepak L. Bhatt - 通讯作者:
Deepak L. Bhatt
AN AGE-PERIOD-COHORT ANALYSIS OF CARDIOVASCULAR DISEASE MORTALITY IN THE UNITED STATES FROM 2000 TO 2019
- DOI:
10.1016/s0735-1097(22)02503-7 - 发表时间:
2022-03-08 - 期刊:
- 影响因子:
- 作者:
Michael Hammond;Natalie Cameron;Nilay Shah;Sadiya Sana Khan - 通讯作者:
Sadiya Sana Khan
STATE-LEVEL VARIATION IN HYPERTENSIVE DISORDERS OF PREGNANCY ASSOCIATED WITH PREPREGNANCY OBESITY IN THE UNITED STATES, 2016-2019
- DOI:
10.1016/s0735-1097(22)02822-4 - 发表时间:
2022-03-08 - 期刊:
- 影响因子:
- 作者:
Priya Mehta;Natalie Cameron;Michael Wang;Sadiya Sana Khan;Lindsay Pool - 通讯作者:
Lindsay Pool
Sadiya Sana Khan的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Sadiya Sana Khan', 18)}}的其他基金
Risk-Based Primary Prevention of Heart Failure
基于风险的心力衰竭一级预防
- 批准号:
10516468 - 财政年份:2022
- 资助金额:
$ 67.79万 - 项目类别:
Risk-Based Primary Prevention of Heart Failure
基于风险的心力衰竭一级预防
- 批准号:
10689211 - 财政年份:2022
- 资助金额:
$ 67.79万 - 项目类别:
CHIcago Center for Accelerating nextGen Omics, deep phenotyping, and data science in Heart Failure (CHICAGO-HF)
芝加哥加速心力衰竭下一代组学、深度表型分析和数据科学中心 (CHICAGO-HF)
- 批准号:
10483161 - 财政年份:2021
- 资助金额:
$ 67.79万 - 项目类别:
CHIcago Center for Accelerating nextGen Omics, deep phenotyping, and data science in Heart Failure (CHICAGO-HF)
芝加哥加速心力衰竭下一代组学、深度表型分析和数据科学中心 (CHICAGO-HF)
- 批准号:
10327554 - 财政年份:2021
- 资助金额:
$ 67.79万 - 项目类别:
PRegnancy OuTcomEs and subclinical Cardiovascular disease sTudy: (PROTECT)
妊娠结局和亚临床心血管疾病研究:(保护)
- 批准号:
10534752 - 财政年份:2021
- 资助金额:
$ 67.79万 - 项目类别:
PRegnancy OuTcomEs and subclinical Cardiovascular disease sTudy: (PROTECT)
妊娠结局和亚临床心血管疾病研究:(保护)
- 批准号:
10345228 - 财政年份:2021
- 资助金额:
$ 67.79万 - 项目类别:
CHIcago Center for Accelerating nextGen Omics, deep phenotyping, and data science in Heart Failure (CHICAGO-HF)
芝加哥加速心力衰竭下一代组学、深度表型分析和数据科学中心 (CHICAGO-HF)
- 批准号:
10679082 - 财政年份:2021
- 资助金额:
$ 67.79万 - 项目类别:
Patterns of Cardiopulmonary health across the life course
整个生命过程中心肺健康的模式
- 批准号:
10459504 - 财政年份:2021
- 资助金额:
$ 67.79万 - 项目类别:
Patterns of Cardiopulmonary health across the life course
整个生命过程中心肺健康的模式
- 批准号:
10280550 - 财政年份:2021
- 资助金额:
$ 67.79万 - 项目类别:
The Role of Plasminogen Activator Inhibitor-1 in the Development and Progression of Obesity
纤溶酶原激活剂抑制剂-1 在肥胖发生和进展中的作用
- 批准号:
8984104 - 财政年份:2015
- 资助金额:
$ 67.79万 - 项目类别:
相似国自然基金
多氯联苯与机体交互作用对生物学年龄的影响及在衰老中的作用机制
- 批准号:82373667
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
恒星模型中氧元素丰度的变化对大样本F、G、K矮星年龄测定的影响
- 批准号:12303035
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
基于年龄和空间的非随机混合对性传播感染影响的建模与研究
- 批准号:12301629
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
母传抗体水平和疫苗初种年龄对儿童麻疹特异性抗体动态变化的影响
- 批准号:82304205
- 批准年份:2023
- 资助金额:20 万元
- 项目类别:青年科学基金项目
中国东部地区大气颗粒物的年龄分布特征及其影响因素的模拟研究
- 批准号:42305193
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
相似海外基金
The Influence of Lifetime Occupational Experience on Cognitive Trajectories Among Mexican Older Adults
终生职业经历对墨西哥老年人认知轨迹的影响
- 批准号:
10748606 - 财政年份:2024
- 资助金额:
$ 67.79万 - 项目类别:
The Proactive and Reactive Neuromechanics of Instability in Aging and Dementia with Lewy Bodies
衰老和路易体痴呆中不稳定的主动和反应神经力学
- 批准号:
10749539 - 财政年份:2024
- 资助金额:
$ 67.79万 - 项目类别:
Understanding the Mechanisms and Consequences of Basement Membrane Aging in Vivo
了解体内基底膜老化的机制和后果
- 批准号:
10465010 - 财政年份:2023
- 资助金额:
$ 67.79万 - 项目类别:
Safety and Tolerability of TASIS-Peanut (Targeted Allergen Specific Immunotherapy within the Skin) patch for the Treatment of Peanut Allergy
TASIS-花生(皮肤内靶向过敏原特异性免疫疗法)贴剂治疗花生过敏的安全性和耐受性
- 批准号:
10551184 - 财政年份:2023
- 资助金额:
$ 67.79万 - 项目类别:
Identifying and Addressing the Effects of Social Media Use on Young Adults' E-Cigarette Use: A Solutions-Oriented Approach
识别和解决社交媒体使用对年轻人电子烟使用的影响:面向解决方案的方法
- 批准号:
10525098 - 财政年份:2023
- 资助金额:
$ 67.79万 - 项目类别: